Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin. 1997

A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
Department of Cell and Molecular Biology, Section for Molecular Pathogenesis, Lund University, P.O. Box 94, S-221 00 Lund, Sweden.

H-kininogen (high-molecular-mass kininogen, HK) is the precursor of the vasoactive peptide hormone bradykinin (BK). Previous work has demonstrated that HK binds to Streptococcus pyogenes through M-proteins, fibrous surface proteins and important virulence factors of these bacteria. Here we find that M-protein-expressing bacteria absorb HK from human plasma. The HK bound to the bacteria was found to be cleaved, and analysis of the degradation pattern suggested that the cleavage of HK at the bacterial surface is associated with the release of BK. Moreover, addition of activated plasma prekallikrein to bacteria preincubated with human plasma, resulted in BK release. This mechanism, by which a potent vasoactive and proinflammatory peptide is generated at the site of infection, should influence the host-parasite relationship during S. pyogenes infections.

UI MeSH Term Description Entries
D007704 Kininogens Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; (HMWK); is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; (LMWK); is split by tissue kallikrein to produce KALLIDIN. Cystatins, Kininogen,Kininogen,Prekinins,Prokinins,T-Kininogen,Thiostatin,Kininogen Cystatins,T Kininogen
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013297 Streptococcus pyogenes A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER. Flesh-Eating Bacteria,Streptococcus Group A,Bacteria, Flesh-Eating

Related Publications

A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
July 1969, Biochemical pharmacology,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
November 2016, Journal of oral biosciences,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
January 2005, Journal of proteome research,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
May 1996, Immunopharmacology,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
October 2004, Glycobiology,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
September 1984, Clinica chimica acta; international journal of clinical chemistry,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
June 1996, Immunopharmacology,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
January 1989, Advances in experimental medicine and biology,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
March 1976, Biochemical pharmacology,
A Ben Nasr, and H Herwald, and U Sjöbring, and T Renné, and W Müller-Esterl, and L Björck
January 2015, PloS one,
Copied contents to your clipboard!